Panitumumab (an anti-EGFR antibody) labeled with IRDye800CW had a higher TNR than 5-ALA in a mouse model.19 Another study used an anti-EGFR antibody cetuximab-IRDye800CW in orthotopic GBM mouse models. Here, EGFR is linked to glioblastoma.